Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Evacyst-OD
- Development stage
- Unknown
- Lead developer
- FEMA Healthcare
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Evacyst-OD is a nutraceutical supplement developed by FEMA Healthcare, an Indian pharmaceutical company. It is formulated as an oral sachet for once-daily (OD) administration and is indicated for women's health conditions. While specific active ingredients are not publicly disclosed by the manufacturer, the product is marketed as a commercial nutritional supplement, likely targeting conditions such as polycystic ovary syndrome (PCOS) or hormonal imbalances. FEMA Healthcare, based in Madurai and Chennai, India, manufactures a range of women's health products, and Evacyst-OD is part of their commercial portfolio rather than an active research and development pipeline candidate.
- Brand names
- Evacyst-OD
Beyond the preview
Go deeper on Evacyst-OD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Evacyst-OD.